Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.910
+0.020 (0.51%)
Nov 6, 2026, 1:50 PM EST - Market open

Oramed Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-2-1.342.72.71
Revenue Growth
----50.42%-0.33%0.33%
Gross Profit
-0.01-1.342.72.71
Operating Income
-14.52-15.09-12.78-15.77-40.6-36.98
Net Income
174.0663.24-19.065.53-36.56-35
Earnings Per Share
4.151.50-0.480.14-0.94-0.94
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
72.48134.27141.93163.85155.72150.16
Total Debt
0.730.830.3751.620.890.5
Net Cash (Debt)
71.75133.44141.56112.23154.83149.66
Net Cash Growth
-26.06%-5.73%26.13%-27.51%3.45%49.21%
Net Cash Per Share
1.703.153.472.773.974.03

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.21-9.15-8.41-10.3-27.92-33.37
Capital Expenditures
-0.01-0.01-0.02-0.25-0.5-0.03
Free Cash Flow
-5.22-9.15-8.43-10.55-28.41-33.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-0.65%-100.00%100.00%100.00%
Operating Margin
--754.40%--1176.79%-1501.96%-1363.50%
Pretax Margin
-3766.20%-379.70%-1393.41%-1355.64%
Profit Margin
-3162.10%-412.31%-1352.61%-1290.71%
FCF Margin
--457.70%--787.24%-1051.20%-1231.31%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.941.79-16.87--
Forward PE
-14.4014.4014.4014.4014.40
PS Ratio
-56.72-69.54174.08200.54